Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Caution evidenceCoverage 5/5 core metricsLatest reported annual revenue changed -11.6% from the prior reported annual observation.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Revenue contracted
Latest reported annual revenue changed -11.6% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2024-12-28.
- Operating margin compressed
Operating margin changed -32.6 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2024-12-28.
- Free cash flow was negative
Latest reported free cash flow was -$18M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2024-12-28.
- 3 filing risk checks flagged
Flagged areas: Solvency & liquidity, Dilution.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
- Dilution
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Subscription Revenues Net$777Mshare n/a-5.6% yoy
- Subscription$777Mshare n/a-5.6% yoy
- Behavioral Subscription Revenues$699Mshare n/a-11.8% yoy
- Clinical Subscription Revenues$78Mshare n/a+155.4% yoy
- Other Revenues Net$8.93Mshare n/a-86.6% yoy
- Other$8.93Mshare n/a-86.6% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$542M69.0%-10.3% yoy
- Other countries$132M16.7%-14.7% yoy
- Germany$82.6M10.5%-14.9% yoy
- Canada$29.7M3.8%-12.1% yoy
Members sum to the consolidated $786M for this period.
- Subscription$167Mshare n/a-9.6% yoy
- Subscription Revenues Net$167Mshare n/a-9.6% yoy
- Behavioral Subscription Revenues$129Mshare n/a-17.5% yoy
- Clinical Subscription Revenues$38.8Mshare n/a+31.8% yoy
- Other Revenues Net$904Kshare n/a-35.0% yoy
- Other$904Kshare n/a-35.0% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
Not available for WW: No stored feature row with a computable metric for this issuer (funds, trusts and 20-F filers are not crawled)..
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 6 changed periods| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Net income NetIncomeLoss | quarter 2022-07-02 | -$4.62M 10-Q 2022-08-04 | -$6.8M 10-K 2024-02-28 | -47.1% | first · latest · 3 filings carry it |
| Interest expense InterestExpense | fiscal year 2023-12-30 | $95.9M 10-K 2024-02-28 | $109M 10-K 2026-03-16 | +13.5% | first · latest · 3 filings carry it |
| Interest expense InterestExpense | quarter 2025-03-29 | $27.6M 10-Q 2025-05-06 | $28.2M 10-Q 2026-05-07 | +2.2% | first · latest |
| Net income NetIncomeLoss | fiscal year 2022-12-31 | -$251M 10-K 2023-03-06 | -$257M 10-K 2025-02-28 | -2.2% | first · latest · 4 filings carry it |
| Interest expense InterestExpense | fiscal year 2024-12-28 | $109M 10-K 2025-02-28 | $111M 10-K 2026-03-16 | +1.5% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2022-01-01 | -$456M 10-K 2022-03-01 | -$453M 10-K 2025-02-28 | +0.8% | first · latest · 9 filings carry it |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for WW yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.